Novolin 70-30 Innolet Side Effects Center

Last updated on RxList: 11/4/2021
Novolin 70-30 Innolet Side Effects Center

What Is Novolin 70-30 Innolet?

Novolin 70/30 InnoLet [70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)] is a form of insulin, a hormone produced in the body, used to treat diabetes. Novolin 70/30 InnoLet is available over-the-counter.

What Are Side Effects of Novolin 70-30 Innolet?

Common side effects of Novolin 70/30 InnoLet include:

  • localized reactions such as red, swollen and itchy skin where the insulin has been injected.

Novolin 70/30 InnoLet can cause low blood sugar (hypoglycemia). Symptoms of low blood sugar include sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. Tell your doctor if you have rare symptoms of insulin allergy including:

  • skin rash over the body,
  • shortness of breath,
  • fast pulse,
  • sweating, and
  • a drop in blood pressure.

Dosage for Novolin 70-30 Innolet

Novolin 70/30 is a mixture of 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin). The concentration of this product is 100 units of insulin per milliliter.

What Drugs, Substances, or Supplements Interact with Novolin 70-30 Innolet?

Novolin 70/30 InnoLet may interact with other drugs. Tell your doctor all medications and supplements you use.

Novolin 70-30 Innolet During Pregnancy or Breastfeeding

Consult your doctor to discuss the best way to manage your diabetes while you are pregnant or breastfeeding.

Additional Information

Our Novolin 70/30 [70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)] Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Diabetes: What Raises and Lowers Your Blood Sugar Level? See Slideshow
Novolin 70-30 Innolet Consumer Information

Get emergency medical help if you have signs of insulin allergy: redness or swelling where an injection was given, itchy skin rash over the entire body, trouble breathing, chest tightness, feeling like you might pass out, or swelling in your tongue or throat.

Call your doctor at once if you have:

  • fluid retention--weight gain, swelling in your hands or feet, feeling short of breath; or
  • low potassium--leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.

Common side effects may include:

  • low blood sugar;
  • weight gain, swelling in your hands or feet;
  • itching, mild skin rash; or
  • thickening or hollowing of the skin where you injected the medicine.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Novolin 70-30 Innolet (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection)

QUESTION

Diabetes is defined best as... See Answer
Novolin 70-30 Innolet Professional Information

SIDE EFFECTS

A few people with diabetes develop red, swollen and itchy skin where the insulin has been injected. This is called a "local reaction" and it may occur if the injection is not properly made, if the skin is sensitive to the cleansing solution, or if you are allergic to the insulin being used. If you have a local reaction, tell your physician.

Generalized insulin allergy occurs rarely, but when it does it may cause a serious reaction, including skin rash over the body, shortness of breath, fast pulse, sweating, and a drop in blood pressure. If any of these symptoms develop, you should seek emergency medical care. If severe allergic reactions to insulin have occurred (i.e., generalized rash, swelling or breathing difficulties) you should be skin-tested with each new insulin preparation before it is used.

Read the entire FDA prescribing information for Novolin 70-30 Innolet (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection)

© Novolin 70-30 Innolet Patient Information is supplied by Cerner Multum, Inc. and Novolin 70-30 Innolet Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors